ArticleEuropean journal of medical research2024

Value of CDR1-AS as a predictive and prognostic biomarker for patients with breast cancer receiving neoadjuvant chemotherapy in a prospective Chinese cohort.

Chenwei Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.